FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Asenapine (Saphris®) Sublingual Tablets
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Allergan (New 03/03/2021)

Company Contact Information:
800-678-1605

Presentation Posting Date Related Information
5 mg (NDC 0456-2405-63) 03/03/2021 The company has made a business decision to discontinue manufacturing this product. All other Saphris® SKU’s remain available.
10 mg (NDC 0456-2410-63) 03/03/2021 The company has made a business decision to discontinue manufacturing this product. All other Saphris® SKU’s remain available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English